search
Back to results

Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

Primary Purpose

Dry Eye

Status
Not yet recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
scleral lens
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Dry Eye

Eligibility Criteria

17 Years - 70 Years (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Are at least 17 years of age and have full legal capacity to volunteer; Have read and signed an information consent letter; Are willing and able to follow instructions and maintain the appointment schedule; Agree to wear the study scleral lenses for at least 8 hours per day, 5 days a week; Have a refraction between +20.00 and -20.00D and spectacle astigmatism of no more than -3.00DC in each eye; Have best corrected visual acuity of 20/40 or better in each eye with the study lenses; Demonstrate an acceptable fit with the study lenses; Have no active ocular disease or inflammation; Group 1: Habitual wearer of frequent replacement or daily disposable soft lenses; Group 2: Have not worn contact lenses for 6 months; Group 1: Contact lens wearers should score ≥12 on CLDEQ-8; Group 2: Non contact lens wearers should score ≥13 on OSDI. Exclusion Criteria: Are participating in any concurrent clinical or research study, or have done so within the past 30 days; Cannot achieve a successful lens fit or vision with the study lens; Have been diagnosed with keratoconus or corneal distortion; Have any known active* ocular condition, disease and/or infection; Have a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable e.g. pingueculae; Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; Group 2: Non-contact lens wearers who score ≥33 on OSDI and also demonstrate either corneal staining ≥3 (Oxford scale) or non-invasive tear break-up time ≤3 seconds#; Have known sensitivity to the diagnostic sodium fluorescein to be used in the study; Are pregnant, lactating or planning a pregnancy^ at the time of enrolment, by self report; Have undergone refractive error surgery; Are listed on the Delegation Log for this study.

Sites / Locations

  • School of Optometry & Vision Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Habitual Soft Lens Wearers

Non Contact Lens Wearers

Arm Description

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.

Outcomes

Primary Outcome Measures

overall ocular comfort
reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps)

Secondary Outcome Measures

Full Information

First Posted
March 23, 2023
Last Updated
August 1, 2023
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05973409
Brief Title
Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye
Official Title
Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 2023 (Anticipated)
Primary Completion Date
August 2023 (Anticipated)
Study Completion Date
August 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is being conducted to determine if scleral lenses coated with Hydra-PED improve comfort and dryness.
Detailed Description
The objective of the study is to determine if scleral lenses with and scleral lenses without Hydra-PEG coating provide positive improvement in ocular comfort and dryness scores. The effect of the study lenses and the coating, will be compared in a group of symptomatic soft lens wearers, and also in a group of symptomatic non contact lens wearers. The primary outcome variable for this study is "overall ocular comfort" reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dry Eye

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Masking Description
At the fitting visit, only uncoated lenses will be used to determine the parameters of the lenses to be ordered. At both dispense visits, participants and investigators will be masked to the lens type dispensed. In order to achieve this, unmasked study personnel will determine the order of lens wear according to the randomization schedule and they will not share the lens labels or packs with the investigator. Instead, the lenses will be transferred to an unmarked case/container prior to being provided at the Dispense visit.
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Habitual Soft Lens Wearers
Arm Type
Experimental
Arm Description
Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.
Arm Title
Non Contact Lens Wearers
Arm Type
Experimental
Arm Description
Each group will be a prospective, randomized, double masked, cross-over, 1-month per arm, daily wear study. Each participant will be active in the study for at least 2 months.
Intervention Type
Device
Intervention Name(s)
scleral lens
Intervention Description
scleral lens with and without hydra-peg coating
Primary Outcome Measure Information:
Title
overall ocular comfort
Description
reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps)
Time Frame
4 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
17 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Are at least 17 years of age and have full legal capacity to volunteer; Have read and signed an information consent letter; Are willing and able to follow instructions and maintain the appointment schedule; Agree to wear the study scleral lenses for at least 8 hours per day, 5 days a week; Have a refraction between +20.00 and -20.00D and spectacle astigmatism of no more than -3.00DC in each eye; Have best corrected visual acuity of 20/40 or better in each eye with the study lenses; Demonstrate an acceptable fit with the study lenses; Have no active ocular disease or inflammation; Group 1: Habitual wearer of frequent replacement or daily disposable soft lenses; Group 2: Have not worn contact lenses for 6 months; Group 1: Contact lens wearers should score ≥12 on CLDEQ-8; Group 2: Non contact lens wearers should score ≥13 on OSDI. Exclusion Criteria: Are participating in any concurrent clinical or research study, or have done so within the past 30 days; Cannot achieve a successful lens fit or vision with the study lens; Have been diagnosed with keratoconus or corneal distortion; Have any known active* ocular condition, disease and/or infection; Have a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable e.g. pingueculae; Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; Group 2: Non-contact lens wearers who score ≥33 on OSDI and also demonstrate either corneal staining ≥3 (Oxford scale) or non-invasive tear break-up time ≤3 seconds#; Have known sensitivity to the diagnostic sodium fluorescein to be used in the study; Are pregnant, lactating or planning a pregnancy^ at the time of enrolment, by self report; Have undergone refractive error surgery; Are listed on the Delegation Log for this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jose Vega, OD, MSc, PhD
Phone
925-621-3761
Email
jvega2@coopervision.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lyndon Jones, PhD
Organizational Affiliation
Director, Centre for Ocular Research and Education
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Optometry & Vision Sciences
City
Waterloo
State/Province
Ontario
ZIP/Postal Code
N2L 3G1
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

We'll reach out to this number within 24 hrs